MRI-identified multidimensional nodal features: predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma: LN feature-based nomogram for stage II NPC . Radiol Oncol. 2022;56(4):479-487. Accessed July 29, 2026. https://www.ojstest.computing.si/index.php/ro/article/view/3963